THE BIOMEDANA RESOURCE LIBRARY

Follow the signal.
Build with evidence.

Fresh perspectives. Practical science. A clearer path from what’s happening to what to do next.

11ISPE 3White papers 2Ebooks 20Industry Insights 8Practical guides 16Use cases 6Scientific evidence 11Comparisons 2Webinars

Industry Insights · 8 min readPythia designs antibodies that change receptor activity. What should a founder advance?

ON OUR RADAR

A perspective worth your time.

All Industry Insights ↗

Conceptual teal antibody engages a violet membrane receptor, with orange paths connecting separate assay and material-characterization stations

Industry Insights

Founder perspective · 8 min read

Pythia designs antibodies that change receptor activity. What should a founder advance?

Pythia Labs’ October 27, 2026 launch reports functional AI-designed antibodies. BioMedAna examines cell activity, developability and the evidence needed for a lead decision.

Read the perspective

Industry Insights · 8 min read

Pythia designs antibodies that change receptor activity. What should a founder advance?

Pythia Labs’ October 27, 2026 launch reports functional AI-designed antibodies. BioMedAna examines cell activity, developability and the evidence needed for a lead decision.

Read the perspective ↗

Blank speech panels become glass specification tiles beside a conceptual teal and violet protein, with orange paths leading to assay cuvettes and a reaction vessel

Industry Insights · 8 min read

Pinal turns words into protein candidates. The experimental brief still needs an owner.

An October 21, 2026 Nature paper introduces Pinal’s natural-language protein design. BioMedAna examines functional briefs, assay context and the step from candidates to useful evidence.

Read the perspective ↗

Conceptual branching violet protein candidates pass through a teal protein search lens toward three orange-linked assay wells

Industry Insights · 8 min read

RFD4-Proteina makes protein search more capable. Who chooses what counts as better?

UW and NVIDIA announced RFD4-Proteina on October 21, 2026. BioMedAna examines search objectives, candidate diversity and the evidence behind a laboratory shortlist.

Read the perspective ↗

Original conceptual workflow showing project records flowing through reaction equations, calibration and held-out evaluation into a reviewed scenario comparison.

Industry Insights · 5 min read

APM in action: kinetic modelling in BioMedAna Twin

How BioMedAna Twin connects reaction records, kinetic equations, parameter fitting, held-out evaluation and what-if scenarios in one scientific workflow.

Read the perspective ↗

01 / 04

EXPLORE AT YOUR PACE

Find your next read.

Search the resource library

77 resourcesIdeas for your next decision

Practical guides

AI-powered soft sensors for bioprocessing

Explore titer, metabolite, biomass and quality prediction with hybrid models, an interactive example and application catalog.

Platform solution · Soft Sensors

BioMedAna biologics scale-up: connected evidence, scientific models and expert review

Use cases

Choose the next scale with engineering evidence

Compare candidate vessel conditions against oxygen transfer, mixing and process-performance evidence before committing an engineering run.

BioMedAna Twin · Decision workflow

BioMedAna technology transfer: connected evidence, scientific models and expert review

Use cases

Make the receiving-site transfer decision explicit

Connect sending-site history, receiving-asset differences and bounded model comparisons to focus the next transfer study.

BioMedAna Twin · Decision workflow

BioMedAna recovery & operating windows: connected evidence, scientific models and expert review

Use cases

Find the process change worth testing next

Compare upstream performance, purification recovery and explicit cost assumptions to choose a better-supported process experiment.

BioMedAna Twin · Decision workflow

BioMedAna facility readiness & ramp-up: connected evidence, scientific models and expert review

Use cases

Connect a new CDMO facility’s design basis to ramp-up evidence

Use a staged evidence and modeling program to compare design assumptions, commissioning results and early operating constraints.

BioMedAna Twin · Decision workflow

BioMedAna line performance & capacity: connected evidence, scientific models and expert review

Use cases

Locate the constraint behind fill-finish and packaging capacity

Frame the evidence and simulation needed to compare throughput losses, changeovers, buffers and product mix across a sterile line.

BioMedAna Twin · Decision workflow

A 2,000 L single-use reference and 10,000 L stainless-steel target connected through engineering, scenario review and prospective evidence

Use cases

Evaluate a 2,000 L single-use to 10,000 L stainless-steel scale-up

Connect the development baseline, vessel engineering and product-quality evidence to decide which large-scale scenario deserves physical confirmation.

BioMedAna Twin · Decision workflow

White papers

Governed Scientific AI for Pharma 4.0

An MSAT operating blueprint for bioprocess investigations: evidence, scientific credibility, governance and investment gates.

White paper · 24 pages · PDF

Ebooks

The Pharma 4.0 Decision Playbook

A leadership workbook for choosing, funding and running one scientific AI workflow, with practical decision records and an honest business case.

Ebook · 27 pages · PDF

Swipe to explore

Showing 9 of 77

Looking for a specific page?Open the complete resource directory ↗

Follow the signal.Build with evidence.

A perspective worth your time.

Pythia designs antibodies that change receptor activity. What should a founder advance?

Pythia designs antibodies that change receptor activity. What should a founder advance?

Pinal turns words into protein candidates. The experimental brief still needs an owner.

RFD4-Proteina makes protein search more capable. Who chooses what counts as better?

APM in action: kinetic modelling in BioMedAna Twin

Find your next read.

AI-powered soft sensors for bioprocessing

Choose the next scale with engineering evidence

Make the receiving-site transfer decision explicit

Find the process change worth testing next

Connect a new CDMO facility’s design basis to ramp-up evidence

Locate the constraint behind fill-finish and packaging capacity

Evaluate a 2,000 L single-use to 10,000 L stainless-steel scale-up

Governed Scientific AI for Pharma 4.0

The Pharma 4.0 Decision Playbook

Follow the signal.
Build with evidence.